相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tertiary lymphoid structure stratifies glioma into three distinct tumor subtypes
Xingwang Zhou et al.
Aging-US (2021)
Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
Ganglei Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy
Jun Wang et al.
BIOMATERIALS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Co-Encapsulation of Fisetin and Cisplatin into Liposomes for Glioma Therapy: From Formulation to Cell Evaluation
Morgane Renault-Mahieux et al.
PHARMACEUTICS (2021)
Correlation between IDH, ATRX, and TERT promoter mutations in glioma
Shigeo Ohba et al.
BRAIN TUMOR PATHOLOGY (2020)
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
Sue Han et al.
BRITISH JOURNAL OF CANCER (2020)
Immunotherapy for glioma: Current management and future application
Shengchao Xu et al.
CANCER LETTERS (2020)
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas
Xiangyang Deng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Classification of diffuse lower-grade glioma based on immunological profiling
Fan Wu et al.
MOLECULAR ONCOLOGY (2020)
Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma
Wen Yin et al.
FRONTIERS IN ONCOLOGY (2020)
Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
Yangzhi Qi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting
Irene Appolloni et al.
CANCER LETTERS (2019)
Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
Wen-Jing Zeng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
Leisha A. Emens et al.
EUROPEAN JOURNAL OF CANCER (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells
Sergey A. Shein et al.
MOLECULAR PHARMACEUTICS (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antagonists of PD-1 and PD-L1 in Cancer Treatment
Evan J. Lipson et al.
SEMINARS IN ONCOLOGY (2015)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
Tumor Immune Evasion
Carlene L. Zindl et al.
SCIENCE (2010)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
分享论文
